Mar. 20 at 9:52 PM
$OSRH The news 👇 on March 19 (Wooori IO signing a mutual NDA with Sinopharm’s Beijing Huahong unit to explore China opportunities for their noninvasive NIR glucose monitoring tech) is huge. Sinopharm is a massive state-owned player in China (~
$81B revenue), with huge distribution reach in healthcare/pharma. This NDA opens the door for deeper talks on regulatory, clinical, and commercial paths in a giant diabetes market.
Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials
https://ca.finance.yahoo.com/news/woori-io-osr-company-signs-134400672.html